Delving into the Latest Updates on Shenzhen Small Molecule New Drug Innovation Center Co., Ltd. with Synapse

Overview

Tags

Congenital Disorders

Immune System Diseases

Respiratory Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Immune System Diseases	1
Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

RET x c-Kit	1

1. Evaluate the safety and tolerability of single/multiple oral administration of ND-003 tablets in healthy adult volunteers. 2. Evaluate the pharmacokinetic characteristics of single/multiple oral administration of ND-003 tablets in healthy adult volunteers. 3. Evaluate the effect of food on the pharmacokinetics of single oral administration of ND-003 tablets in healthy adult volunteers.

Start Date06 May 2024

Sponsor / Collaborator

Shenzhen Small Molecule New Drug Innovation Center Co., Ltd.

[+1]

NCT06169579 / Enrolling by invitationPhase 1

A Single-arm, Non-randomized, Open-label, Dose-escalation and Dose-expansion, Multicenter Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles, as Well as Preliminary Efficacy, of ND-003 in Chinese Patients With Advanced Solid Tumors.

This study is done to test the safety and preliminary efficacy of drug ND-003 tablets in patients with solid tumors. ND-003 is a highly potent and selective small molecular inhibitor of NTRK (neurotrophic receptor tyrosine kinase) and RET (rearranged during transfection). The study also investigates how the drug is absorbed and processed in the human body.

Start Date04 Feb 2024

Sponsor / Collaborator

Shenzhen NewDEL Biotech Co., Ltd

[+1]

100 Clinical Results associated with Shenzhen Small Molecule New Drug Innovation Center Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Shenzhen Small Molecule New Drug Innovation Center Co., Ltd.

Login to view more data

100 Deals associated with Shenzhen Small Molecule New Drug Innovation Center Co., Ltd.

Login to view more data

100 Translational Medicine associated with Shenzhen Small Molecule New Drug Innovation Center Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1 Clinical

1

Login to view more data